← Back to Search

Procedure

Computer-Assisted Hip Replacement for Improved Surgical Accuracy

N/A

Waitlist Available

Led By Paul Kuzyk, MD

Research Sponsored by Mount Sinai Hospital, Canada

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Any patient who is undergoing a primary total hip arthroplasty at Mount Sinai Hospital.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 weeks and 1 year post-op

Awards & highlights

Study Summary

This trial is testing whether a new, computer-assisted method for hip replacement surgery is more accurate than the standard method in terms of leg length and hip offset.

Who is the study for?

This trial is for patients at Mount Sinai Hospital who are getting their first total hip arthroplasty. It's not suitable for those with a pre-operative flexion contracture greater than 30 degrees, an infection, or if rigid fixation of instruments can't be achieved during surgery.Check my eligibility

What is being tested?

The study tests the Intellijoint HIP™ system's accuracy in measuring leg length and hip offset against the standard pin and outrigger method during primary total hip arthroplasty to see if it can reduce discrepancies.See study design

What are the potential side effects?

While specific side effects aren't listed for using Intellijoint HIP™, typical risks may include issues related to surgical instrument use such as tissue irritation or inaccurate measurements leading to complications.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am having my first total hip replacement at Mount Sinai Hospital.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks and 1 year post-op

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks and 1 year post-op

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks and 1 year post-op for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Accuracy of Hip Offset

Accuracy of leg length

Secondary outcome measures

Dislocation Rates

Harris Hip Score

Oxford Hip Scores

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intellijoint HIPExperimental Treatment1 Intervention

Patient's will have their leg length and hip offset determined intraoperatively using Intellijoint HIP.

Group II: OutriggerActive Control1 Intervention

Control patients will have their leg length and hip offset determined intra-operatively using the standard at Mount Sinai Hospital, which is a pin and outrigger system.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Mount Sinai Hospital, CanadaLead Sponsor

196 Previous Clinical Trials

67,480 Total Patients Enrolled

Paul Kuzyk, MDPrincipal InvestigatorMount Sinai Hospital, Division of Orthopedic Surgery

1 Previous Clinical Trials

160 Total Patients Enrolled

Media Library

Hip Osteoarthritis Research Study Groups: Intellijoint HIP, Outrigger

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any participants currently being enrolled in this clinical test?

"Clinicaltrials.gov discloses that this trial, initially posted on March 1st 2014 and last revised in March 20th of the same year, is not presently recruiting patients. However, there are currently 99 other clinical trials actively seeking participants at this moment in time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

An Intelligent Instrument for Improved Leg Length and Hip Offset Accuracy in Total Hip Arthroplasty

2014. "An Intelligent Instrument for Improved Leg Length and Hip Offset Accuracy in Total Hip Arthroplasty". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02095093.